Literature DB >> 28141666

Menopausal symptom clusters and their correlates in women with and without a history of breast cancer: a pooled data analysis from the Women's Wellness Research Program.

Charrlotte Seib1, Janine Porter-Steele, Amanda McGuire, Alexandra McCarthy, Sarah Balaam, Debra J Anderson.   

Abstract

OBJECTIVES: This analysis examined climacteric symptoms clusters in women with and without breast cancer, and explored how sociodemographic, health, and modifiable lifestyle factors predicted symptom clusters.
METHODS: This pooled analysis of four Women's Wellness Research Program (WWRP) studies comprised individual-level data from 969 Australian women aged 40 to 63 years, 293 of whom had been previously treated for breast cancer and 678 without a breast cancer history. Climacteric symptoms, menopausal status, sociodemographic characteristics, and health and lifestyle factors were assessed. Principal component analysis was used to determine symptom clusters for each group separately before linear regression with backwards selection was used to identify the significant correlates of the identified clusters.
RESULTS: Women with a history of breast cancer reported more sleep disturbance (P < 0.01), difficulty concentrating (P < 0.01), muscular/joint pain (P < 0.01), crying (P < 0.01) and irritability (P < 0.01), and vasomotor symptoms (P < 0.01) than women from the noncancer group. Principal component analysis with quartimax rotation revealed two distinct solutions explaining 60.9% and 57.6% of the variance in the groups, respectively. For both groups, symptom clusters were increased among those with unhealthy lifestyle behaviors (and chemotherapy among the after cancer group, P < 0.05 for all), though to a lesser extent in the breast cancer group.
CONCLUSIONS: In this study, women after treatment for breast cancer reported a broad range of bothersome climacteric symptoms. Similar symptom clusters were also noted for women with and without a history of breast cancer, though correlates differed across groups, and might reflect different underlying etiologies.

Entities:  

Mesh:

Year:  2017        PMID: 28141666     DOI: 10.1097/GME.0000000000000810

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  6 in total

1.  Symptom Clusters in Breast Cancer Survivors: A Latent Class Profile Analysis.

Authors:  Lena Lee; Alyson Ross; Kathleen Griffith; Roxanne E Jensen; Gwenyth R Wallen
Journal:  Oncol Nurs Forum       Date:  2020-01-01       Impact factor: 2.172

2.  Who is managing menopausal symptoms, sexual problems, mood and sleep disturbance after breast cancer and is it working? Findings from a large community-based survey of breast cancer survivors.

Authors:  Michelle Peate; Christobel Saunders; Paul Cohen; Martha Hickey
Journal:  Breast Cancer Res Treat       Date:  2021-02-11       Impact factor: 4.872

3.  Stability of Symptom Clusters in Patients With Breast Cancer Receiving Chemotherapy.

Authors:  Carmen W Sullivan; Heather Leutwyler; Laura B Dunn; Bruce A Cooper; Steven M Paul; Jon D Levine; Marilyn Hammer; Yvette P Conley; Christine A Miaskowski
Journal:  J Pain Symptom Manage       Date:  2017-08-31       Impact factor: 3.612

4.  Differences in symptom clusters before and twelve months after breast cancer surgery.

Authors:  Melissa Mazor; Janine K Cataldo; Kathryn Lee; Anand Dhruva; Bruce Cooper; Steven M Paul; Kimberly Topp; Betty J Smoot; Laura B Dunn; Jon D Levine; Yvette P Conley; Christine Miaskowski
Journal:  Eur J Oncol Nurs       Date:  2017-12-19       Impact factor: 2.398

5.  Symptom clusters in outpatients with cancer using different dimensions of the symptom experience.

Authors:  Carolyn S Harris; Kord M Kober; Bruce Cooper; Yvette P Conley; Anand A Dhruva; Marilyn J Hammer; Steven Paul; Jon D Levine; Christine A Miaskowski
Journal:  Support Care Cancer       Date:  2022-05-11       Impact factor: 3.603

6.  Vasomotor symptoms in midlife women with incident breast cancer: pink SWAN.

Authors:  Ellen B Gold; Sybil L Crawford; Katherine Leung; Gail Greendale; Katherine W Reeves; Hadine Joffe; Nancy E Avis
Journal:  Breast Cancer Res Treat       Date:  2021-10-25       Impact factor: 4.624

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.